Tao reported that PRMT1 acts as an inhibitor of CD8+ T-cell recruitment and activation in melanoma and that deletion of PRMT1 reduces the abundance of H3K27ac and H4R3me2a in the Dnmt1 enhancer region, thereby reducing Dnmt1 expression in melanoma cells [35]. The gene discussed is CD8A; the disease is melanoma.